Recent developments, including the May 2026 resignation of FDA Commissioner Marty Makary amid policy tensions, have elevated Kyle Diamantas to acting commissioner, driving trader consensus toward him as the likely formal nominee. As deputy commissioner for food and a figure with ties to administration priorities on food safety and regulatory reform, Diamantas benefits from immediate institutional continuity and White House support. Other candidates such as Stephen Hahn, Brett Giroir, Sara Brenner, and Grace Graham appear as longer shots, with limited recent signals of advancement. The 16% probability of no announcement by year-end accounts for Senate confirmation timelines and the administration's focus on broader health agency transitions. This positioning aligns with historical patterns where acting officials often secure permanent roles when backed by executive momentum.